Li Kang Biomedical Co., Ltd.
TWO: 6242.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Yu-Xiu Zheng
- Employees
- 130
- Headquarters
- Tainan City, Taiwan
- IPO year
- 2007
- Market cap
- NT$1.2B
- Website
- https://www.likangbio.com
Loading 6242…
Loading profile data…Frequently asked questions about 6242
What does Li Kang Biomedical Co., Ltd. (6242.TWO) do?
Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd. in Septem...
Where does 6242.TWO trade?
Li Kang Biomedical Co., Ltd. (6242.TWO) trades on the Taipei Exchange.
What sector is 6242.TWO in?
Li Kang Biomedical Co., Ltd. (6242.TWO) operates in the Consumer Defensive sector, specifically in the Household & Personal Products industry.
Who is the CEO of Li Kang Biomedical Co., Ltd.?
Yu-Xiu Zheng is the chief executive officer of Li Kang Biomedical Co., Ltd. (6242.TWO).
Where is Li Kang Biomedical Co., Ltd. headquartered?
Li Kang Biomedical Co., Ltd. is headquartered in Taiwan.
Does 6242.TWO pay a dividend?
Yes — Li Kang Biomedical Co., Ltd. (6242.TWO) paid a trailing twelve-month dividend of TWD 2.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6242.TWO go public?
Li Kang Biomedical Co., Ltd. (6242.TWO) completed its initial public offering in 2007.